You are here

Article info

Article menu
Coronary artery disease
Original research
Sildenafil’s effectiveness in the primary coronary slow flow phenomenon: a pilot randomised controlled clinical trial

Authors

  • Abbas Andishmand Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran PubMed articlesGoogle scholar articles
  • Seyedmostafa Seyedhosseini Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran PubMed articlesGoogle scholar articles
  • Seyedeh Mahdieh Namayandeh Epidemiologist, Associated Professor, Afshar Research Development Center, Yazd, Iran Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran PubMed articlesGoogle scholar articles
  • Elnaz Adelzadeh Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran PubMed articlesGoogle scholar articles
  • Amin Entezari Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran PubMed articlesGoogle scholar articles
  • Seyed Reza Mirjalili Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amin Entezari; aminentezari.2013{at}gmail.com
View Full Text

Citation

Andishmand A, Seyedhosseini S, Namayandeh SM, et al
Sildenafil’s effectiveness in the primary coronary slow flow phenomenon: a pilot randomised controlled clinical trial
Open Heart 2024;11:e002772. doi: 10.1136/openhrt-2024-002772

Publication history

  • Received June 17, 2024
  • Accepted August 13, 2024
  • First published August 25, 2024.
Online issue publication 
August 25, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.